863 related articles for article (PubMed ID: 16966019)
1. Systemic and localized scleroderma.
Chung L; Lin J; Furst DE; Fiorentino D
Clin Dermatol; 2006; 24(5):374-92. PubMed ID: 16966019
[TBL] [Abstract][Full Text] [Related]
2. [Systemic sclerosis].
Tamborrini G; Distler M; Distler O
Med Monatsschr Pharm; 2008 May; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
[TBL] [Abstract][Full Text] [Related]
3. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
4. Scleroderma--clinical and pathological advances.
Denton CP; Black CM
Best Pract Res Clin Rheumatol; 2004 Jun; 18(3):271-90. PubMed ID: 15158741
[TBL] [Abstract][Full Text] [Related]
5. [The fibrotic diseases of the skin].
Kähäri VM; Reitamo S; Granlund H; Uitto J
Duodecim; 1991; 107(12):957-70. PubMed ID: 1364453
[No Abstract] [Full Text] [Related]
6. [Systemic sclerosis--clinical course and treatment possibilities].
Szymańska E; Maj M; Rudnicka L
Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
[TBL] [Abstract][Full Text] [Related]
7. Localized scleroderma and systemic sclerosis: is there a connection?
Gupta RA; Fiorentino D
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859
[TBL] [Abstract][Full Text] [Related]
8. Morphea and localized scleroderma in children.
Vierra E; Cunningham BB
Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
[TBL] [Abstract][Full Text] [Related]
9. Fibrosing conditions in childhood.
Falanga V
Adv Dermatol; 1991; 6():145-58; discussion 159. PubMed ID: 1983952
[No Abstract] [Full Text] [Related]
10. Systemic sclerosis/scleroderma: a treatable multisystem disease.
Hinchcliff M; Varga J
Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
[TBL] [Abstract][Full Text] [Related]
11. [The clinical picture of morphea].
Wojas-Pelc A; Wielowieyska-Szybińska D
Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic and therapeutic problems of scleroderma].
Pogorzelska-Antkowiak A; Antkowiak R
Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous manifestations of selected rheumatologic diseases.
Ostezan LB; Callen JP
Am Fam Physician; 1996 Apr; 53(5):1625-36. PubMed ID: 8623690
[TBL] [Abstract][Full Text] [Related]
14. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
Li SC
Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497
[TBL] [Abstract][Full Text] [Related]
15. [How to recognize scleroderma].
Francès C; Ayoub N; Barete S
Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy for systemic sclerosis.
Steen V
Autoimmun Rev; 2006 Feb; 5(2):122-4. PubMed ID: 16431341
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic management of acral manifestations of systemic sclerosis].
Meyer MF; Daigeler A; Lehnhardt M; Steinau HU; Klein HH
Med Klin (Munich); 2007 Mar; 102(3):209-18. PubMed ID: 17345017
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients.
Khurram M; Skov L; Rossen K; Thomsen HS; Marckmann P
Scand J Urol Nephrol; 2007; 41(6):565-6. PubMed ID: 17934986
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
Doyle JA; Connolly SM; Winkelmann RK
Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
[TBL] [Abstract][Full Text] [Related]
20. [Renal involvement in systemic sclerosis].
Guerini S; Cavazzana I; Venturelli C; Rozzi M; Turina S; Sottini L; Tardanico R; Franceschini F; Scolari F
G Ital Nefrol; 2007; 24(4):295-310. PubMed ID: 17659501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
